Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism 4-1BB inhibitors(Tumor necrosis factor receptor superfamily member 9 inhibitors), CD3 inhibitors(T cell surface glycoprotein CD3 inhibitors), WT1 inhibitors(Wilms' Tumour 1 inhibitors) + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | CN | 14 Apr 2023 |